Deep tech and medical imaging company Oxford Enhanced Medical has rebranded to Sonosine in a company rebrand taking effect from today.
Sonosine’s patented Electro Magnetic Acoustic imaging (EMA) technology, embedded in its first product the Pulsar 1, is what the company says is a step-change in medical imaging and the first significant development in this field for many years.
CEO David Herbada said that the Sonosine team will be working throughout 2021 to reduce the time that it takes to get to market by fostering and developing its relationships with a range of different players in the medical imaging world.
He said: “Sonosine’s new branding and name, signals an intention to step-up in 2021 and beyond, to take our first product, the Pulsar 1, through commercial development, ultimately putting it into the hands of medical specialists.
“We are motivated by the drive to do this because we believe that medical imaging procedures should be accessible and affordable to all, including the billion plus population in less economically privileged countries.”
